Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Generalized Myasthenia Gravis”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Very early researchNot Yet RecruitingNCT06485232
What this trial is testing

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMyasthenia Gravis, GeneralizedMultiple Sclerosis+1 more
Xuanwu Hospital, Beijing 25
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Large-scale testing (Phase 3)Study completedNCT06764160
What this trial is testing

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG

Who this might be right for
Generalized Myasthenia Gravis (gMG)Refractory gMG
Alexion Pharmaceuticals, Inc. 15
Very early researchStudy completedNCT04431895
What this trial is testing

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Who this might be right for
Myasthenia Gravis, Generalized
Huashan Hospital 19
Early research (Phase 1)Looking for participantsNCT06688435
What this trial is testing

Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT03759366
What this trial is testing

Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Juvenile FormMyasthenia Gravis, Generalized
Alexion Pharmaceuticals, Inc. 12
Not applicableNot Yet RecruitingNCT07499323
What this trial is testing

Talquetamab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis (MG)
First Affiliated Hospital of Chongqing Medical University 2
Very early researchWithdrawnNCT06419166
What this trial is testing

An Exploratory Clinical Study of GC012F Injection for Refractory gMG

Who this might be right for
Refractory Generalized Myasthenia Gravis
Zhejiang University
Early research (Phase 1)Not Yet RecruitingNCT06958939
What this trial is testing

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Ting Chang, MD 24
Very early researchLooking for participantsNCT07058298
What this trial is testing

GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Daishi Tian 6
Early research (Phase 1)Looking for participantsNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Early research (Phase 1)Not Yet RecruitingNCT06759948
What this trial is testing

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Chongbo Zhao 18
Early research (Phase 1)Looking for participantsNCT06371040
What this trial is testing

Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Ting Chang, MD 9
Large-scale testing (Phase 3)Study completedNCT01997229
What this trial is testing

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 125
Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Not applicableActive Not RecruitingNCT06700616
What this trial is testing

A Study in Patients With Myasthenia Gravis in China

Who this might be right for
Myasthenia Gravis
AstraZeneca 1,199